Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemoradiation for unresectable cutaneous squamous cell carcinoma
ACTRN12607000534482Phase 2Completed
- Sponsor
- Kazia Therapeutics
- Start
- Jan 2009
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cisplatin and carboplatin in cutaneous squamous cell carcinoma (cSCC), sponsored by Kazia Therapeutics. Primary endpoint: Complete response rate. Started Jan 2009; status: completed.
02
Drugs
cisplatincarboplatin
03
Conditions
cutaneous squamous cell carcinoma (cSCC)
Beyond the preview
Go deeper on ACTRN12607000534482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12607000534482.